LYTIR

Insider · SEC Form 4 · 10% Owner, Emeritus Director

Jack W. Schuler

Filed with the SEC as SCHULER JACK W; the order above is the one the filer's own signature uses.

In the 12 months to Nov 19, 2026, on the open market: bought $2.0M of BDSX. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $2.0M in total; Insider sales: $0 in total.Aug: Insider purchases $1.0MNov: Insider purchases $1.0MDecJanFebMarAprMayJunJulAugSepOctNov$1.0M
Insider purchases above the line: $2.0MInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. BDSXBought: BIODESIX INC Nov 10, 2026 100,000 shares filed Nov 12, 2026 655,810 shares held indirectly after, as filed filing $1.0M
  2. BDSXBought: BIODESIX INC Aug 12, 2026 15,000 shares filed Aug 13, 2026 555,810 shares held indirectly after, as filed filing $367K
  3. BDSXBought: BIODESIX INC Aug 11, 2026 13,700 shares filed Aug 12, 2026 540,810 shares held indirectly after, as filed filing $329K
  4. BDSXBought: BIODESIX INC Aug 10, 2026 13,900 shares filed Aug 12, 2026 527,110 shares held indirectly after, as filed filing $337K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Stakes filed (13D/13G)

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Filings made under this filer's SEC CIK in the same 12 months, newest first; the figure is the percentage the filing states. Every recent 13D and 13G

  1. BDSXSCHULER JACK W filed Nov 12, 2026 Schedule 13D/A may seek influence 2,476,545 shares issuer: BIODESIX INC filing 22.3%
  2. AWHLSCHULER JACK W filed Jun 11, 2026 Schedule 13D/A may seek influence 4,052,587 shares issuer: Aspira Women's Health Inc. filing 8.7%